Inhibition by suramin of protein synthesis in vitro. Ribosomes as the target of the drug

Biochimie

Volumn 88, Issue 5, 2006, Pages 497-503

  Brigotti, Maurizio ^a   Alfieri, Roberta R ^b   Petronini, Pier Giorgio ^b   Carnicelli, Domenica ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Cell free systems; Eukaryotic translation; Ribosomes; Suramin

Indexed keywords

PROTEIN SUBUNIT; SURAMIN; TRITIUM; RIBOSOME PROTEIN; RIBOSOME RNA;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; IN VITRO STUDY; NONHUMAN; PROTEIN SYNTHESIS; RIBOSOME; ANIMAL; CELL FREE SYSTEM; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; GENETICS; METABOLISM; PHYSIOLOGY; POLYSOME; RABBIT; RETICULOCYTE; RNA TRANSLATION;

EUKARYOTA; ORYCTOLAGUS CUNICULUS;

ANIMALS; CELL-FREE SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; MOLECULAR STRUCTURE; PEPTIDE CHAIN INITIATION, TRANSLATIONAL; POLYRIBOSOMES; PROTEIN BIOSYNTHESIS; RABBITS; RETICULOCYTES; RIBOSOMAL PROTEINS; RIBOSOMES; RNA, RIBOSOMAL; SURAMIN;

EID: 33744974772     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2005.10.009     Document Type: Article

References (23)

1. La Rocca R.V., Stein C.A., and Myers C.E. Suramin: prototype of a new generation of antitumor compounds. Cancer Cells 2 (1990) 106-115
2. De Clercq E. Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses. Cancer Lett. 8 (1979) 9-22
3. Mitsuya H., Popovic M., Yarchoan R., Matsushita S., Gallo R.C., and Broder S. Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III. Science 226 (1984) 172-174
4. Eichhorst S.T., Krueger A., Müerköster S., Fas S.C., Golks A., Gruetzner U., Schubert L., Opelz C., Bilzer M., Gerbes A.L., and Krammer P.H. Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nat. Med. 10 (2004) 602-609
5. Armand J.P., and Cvitkovic E. Suramin: a new therapeutic concept. Eur. J. Cancer 26 (1990) 417-419
6. Hawking F. Suramin: with special reference to onchocerciasis. Adv. Pharmacol. Chemother. 15 (1978) 289-322
7. Macadam R.F., and Williamson J. Drug effects on the fine structure of Trypanosoma rhodesiense: suramin, tryparsamide and mapharside. Ann. Trop. Med. Parasitol. 68 (1974) 301-306
8. Kahan D., Zahalsky A.C., and Hutner S.H. Protein synthesis in cell-free preparations of Crithidia fasciculata. J. Protozool. 15 (1968) 385-390
9. Brigotti M., Petronini P.G., Carnicelli D., Alfieri R.R., Bonelli M.A., Borghetti A.F., and Wheeler K.P. Effects of osmolarity, ions and compatible osmolytes on cell-free protein synthesis. Biochem. J. 369 (2003) 369-374
10. Allen E.H., and Schweet R.S. Synthesis of hemoglobin in a cell-free system. Properties of the complete system. J. Biol. Chem. 237 (1962) 760-767
11. Brigotti M., Rambelli F., Zamboni M., Montanaro L., and Sperti S. Effect of alpha-sarcin and ribosome-inactivating proteins on the interaction of elongation factors with ribosomes. Biochem. J. 257 (1989) 723-727
12. Schreier M.H., and Staehelin T. Initiation of mammalian protein synthesis: the importance of ribosome and initiation factor quality for the efficiency of in vitro systems. J. Mol. Biol. 73 (1973) 329-349
13. Sierra J.M., Meier D., and Ochoa S. Effect of development on the translation of messenger RNA in Artemia salina embryos. Proc. Natl. Acad. Sci. USA 71 (1974) 2693-2697
14. Kroczek R.A., and Siebert E. Optimization of northern analysis by vacuum-blotting, RNA-transfer visualization, and ultraviolet fixation. Anal. Biochem. 184 (1990) 90-95
15. Siegelman F., and Apirion D. Aurintricarboxylic acid, a preferential inhibitor of initiation of protein synthesis. J. Bacteriol. 105 (1971) 902-907
16. Legon S., Jackson R.J., and Hunt T. Control of protein synthesis in reticulocyte lysate by haemin. Nature New Biol. 241 (1973) 150-152
17. Avliyakulov N.K., Lukeš J., Kajava A.V., Liedberg B., Lundström I., and Svensson S.P.S. Suramin blocks nucleotide triphosphate binding to ribosomal protein L3 from Trypanoplasma borreli. Eur. J. Biochem. 267 (2000) 1723-1731
18. Voogd T.E., Vansterkenburg E.L.M., Wilting J., and Janssen L.H.M. Recent research on the biological activity of suramin. Pharmacol. Rev. 45 (1993) 177-203
19. Fairlamb A.H., and Bowman I.B.R. Trypanosoma brucei: suramin and other trypanocidal compounds' effects on sn-glycerol-3-phosphate oxidase. Exp. Parasitol. 43 (1977) 353-361
20. Wang C.C. Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis. Annu. Rev. Pharmacol. Toxicol. 35 (1995) 93-127
21. Howells R.E., Mendis A.M., and Bray P.G. The action of suramin on Brugia pahangi. Parasitology 87 (1983) 29-48
22. Morty R.E., Troeberg L., Pike R.N., Jones R., Nickel P., Lonsdale-Eccles J.D., and Coetzer T.H.T. A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine diminazene and suramin. FEBS Lett. 433 (1998) 251-256
23. Scott A.G., Tait A., and Turner M.R. Characterisation of cloned lines of Trypanosoma brucei expressing stable resistance to MelCy and suramin. Acta Trop. 60 (1996) 251-262